Olopatadine nasal spray for the treatment of seasonal allergic rhinitis in patients aged 6 years and older

被引：7
作者：
Roland, Peter S. [1 ]
Ryan, Matthew W. [1 ]
Wall, G. Michael [2 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dept Otolaryngol Head & Neck Surg, Dallas, TX 75390 USA
[2] Alcon Res Ltd, Ft Worth, TX 76134 USA
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2010年 / 11卷 / 09期
关键词：
allergic rhinitis; allergic rhinosinusitis; antihistamine; mast cell stabilizer; nasal spray; olopatadine hydrochloride; Patanase (R) Nasal Spray; QUALITY-OF-LIFE; HYDROCHLORIDE; MANAGEMENT; EFFICACY; SAFETY; PATHOPHYSIOLOGY; QUESTIONNAIRE; 0.6-PERCENT; PREFERENCE; STATEMENT;
D O I：
10.1517/14656566.2010.485609
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Importance of the field: Allergic rhinitis is an IgE-mediated condition that produces inflammation of the mucosa of the nose, paranasal sinuses and, frequently, of the ocular conjunctiva. Allergic rhinitis causes a significant disease burden in terms of quality of life, lost productivity and medical treatment costs. One of the newest treatments approved by the FDA is Patanase (R) (olopatadine hydrochloride) Nasal Spray, 665 mu g/spray (OLO). Olopatadine is an antihistamine with selective H(1)-receptor antagonist activity. Areas covered in this review: This review details the basic and clinical research on the olopatadine molecule and OLO nasal spray from 1996 to the present day. What the reader will gain: The reader will gain a better understanding of the pharmacology of OLO nasal spray, the clinical trial data that have established the efficacy of OLO nasal spray and the overall role of OLO nasal spray in the management of allergic rhinitis. Take home message: Olopatadine nasal spray is one of the newest treatments approved by the FDA for the management of allergic rhinitis. OLO has a rapid onset of action, efficacy comparable to intranasal steroid sprays and is approved for seasonal allergic rhinitis in patients aged >= 6 years.
引用
收藏
页码：1559 / 1567
页数：9
相关论文
共 38 条
[1]  
*AM AC ALL ASTH IM, ALL REP
[2]   Safety and efficacy of olopatadine hydrochloride nasal spray 0.6% in pediatric subjects with allergic rhinitis [J].
Berger, William E. ;
Ratner, Paul H. ;
Casale, Thomas B. ;
Meltzer, Eli O. ;
Wall, G. Michael .
ALLERGY AND ASTHMA PROCEEDINGS, 2009, 30 (06) :612-623
[3]   Allergic rhinitis management pocket reference 2008 [J].
Bousquet, J. ;
Reid, J. ;
van Weel, C. ;
Cagnani, C. Baena ;
Canonica, G. W. ;
Demoly, P. ;
Denburg, J. ;
Fokkens, W. J. ;
Grouse, L. ;
Mullol, K. ;
Ohta, K. ;
Schermer, T. ;
Valovirta, E. ;
Zhong, N. ;
Zuberbier, T. .
ALLERGY, 2008, 63 (08) :990-996
[4]   ASSESSMENT OF QUALITY-OF-LIFE IN PATIENTS WITH PERENNIAL ALLERGIC RHINITIS WITH THE FRENCH VERSION OF THE SF-36 HEALTH-STATUS QUESTIONNAIRE [J].
BOUSQUET, J ;
BULLINGER, M ;
FAYOL, C ;
MARQUIS, P ;
VALENTIN, B ;
BURTIN, B .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 94 (02) :182-188
[5]   Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis [J].
Corren, J ;
Storms, W ;
Bernstein, J ;
Berger, W ;
Nayak, A ;
Sacks, H .
CLINICAL THERAPEUTICS, 2005, 27 (05) :543-553
[6]   Diagnosis and Management of Rhinitis: Complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology [J].
Dykewicz, MS ;
Fineman, S ;
Skoner, DP ;
Nicklas, R ;
Lee, R ;
Blessing-Moore, J ;
Li, JT ;
Bernstein, IL ;
Berger, W ;
Spector, S ;
Schuller, D .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1998, 81 (05) :478-518
[7]  
FAIRCHILD CJ, 2007, ALLERGY ASTHMA PROC, V28, P1
[8]   Allergic rhinitis: Impact of the disease and considerations for management [J].
Greiner, AN .
MEDICAL CLINICS OF NORTH AMERICA, 2006, 90 (01) :17-+
[9]   Once-daily administration of intranasal corticosteroids for allergic rhinitis: A comparative review of efficacy, safety, patient preference, and cost [J].
Herman, Howard .
AMERICAN JOURNAL OF RHINOLOGY, 2007, 21 (01) :70-79
[10]   ASSESSMENT OF QUALITY-OF-LIFE IN ADOLESCENTS WITH ALLERGIC RHINOCONJUNCTIVITIS - DEVELOPMENT AND TESTING OF A QUESTIONNAIRE FOR CLINICAL-TRIALS [J].
JUNIPER, EF ;
GUYATT, GH ;
DOLOVICH, J .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 93 (02) :413-423
1234